These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27554947)

  • 21. Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?
    Paciaroni M; Agnelli G
    Thromb Haemost; 2014 Jan; 111(1):14-8. PubMed ID: 24258528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All-cause and bleeding-related health care costs in warfarin-treated patients with atrial fibrillation.
    Ghate SR; Biskupiak J; Ye X; Kwong WJ; Brixner DI
    J Manag Care Pharm; 2011 Nov; 17(9):672-84. PubMed ID: 22050392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation.
    Lamsam L; Sussman ES; Iyer AK; Bhambhvani HP; Han SS; Skirboll S; Ratliff JK
    Stroke; 2018 Aug; 49(8):1866-1871. PubMed ID: 29991654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
    Gennaro N; Ferroni E; Zorzi M; Denas G; Pengo V
    Int J Cardiol; 2024 Jan; 394():131369. PubMed ID: 37722453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.
    Tagaya M; Yoshikawa D; Sugishita Y; Yamauchi F; Ito T; Kamada T; Yoshinaga M; Mukaide D; Fujiwara W; Yokoi H; Hayashi M; Watanabe E; Ishii J; Ozaki Y; Izawa H
    Heart Vessels; 2016 Jun; 31(6):957-62. PubMed ID: 26022376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of stroke in patients with atrial fibrillation.
    Olsson SB; Halperin JL
    Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study.
    Brønnum Nielsen P; Larsen TB; Gorst-Rasmussen A; Skjøth F; Rasmussen LH; Lip GYH
    Chest; 2015 Jun; 147(6):1651-1658. PubMed ID: 25412369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
    Romero J; Cerrud-Rodriguez RC; Diaz JC; Rodriguez D; Arshad S; Alviz I; Cerna L; Rios S; Monhanty S; Natale A; Garcia MJ; Di Biase L
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1250-1257. PubMed ID: 31257677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of catheter ablation for atrial fibrillation in patients with intracranial hemorrhage.
    Lin H; Li SN; Bai R; Wen SN; Liu N; Long DY; Yu RH; Tang RB; Sang CH; Du X; Dong JZ; Ma CS
    Herz; 2018 Mar; 43(2):169-176. PubMed ID: 28314875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between Anticoagulation, Risk Scores and Adverse Outcomes in Dialysis Patients with Atrial Fibrillation.
    Wang TK; Sathananthan J; Marshall M; Kerr A; Hood C
    Heart Lung Circ; 2016 Mar; 25(3):243-9. PubMed ID: 26481398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study.
    Casu G; D'Angelo G; Ugo F; Ronco F; Simonetto F; Barbierato M; Magni V; Boccuzzi G; Margonato A; Moroni F; Delitala A; Lorenzoni G; Beneduce A; Rametta F; Mazzone P; Della Bella P; Montorfano M; Merella P
    Int J Cardiol; 2021 Apr; 328():75-80. PubMed ID: 33245957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
    Toso E; Peyracchia M; Matta M; D'Ascenzo F; Gaita F; Kornej J; Hindricks G; Jared Bunch T; Saliba W
    Int J Cardiol; 2018 Nov; 270():172-179. PubMed ID: 29945808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual Aid Tool to Improve Decision Making in Anticoagulation for Stroke Prevention.
    Saposnik G; Joundi RA
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2380-5. PubMed ID: 27318647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalizing Bridging Anticoagulation in Patients with Nonvalvular Atrial Fibrillation-a Microsimulation Analysis.
    Pappas MA; Barnes GD; Vijan S
    J Gen Intern Med; 2017 Apr; 32(4):464-470. PubMed ID: 28120297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Uninterrupted Low-Intensity Warfarin for Radiofrequency Catheter Ablation of Atrial Fibrillation in the Elderly.
    Xing Y; Xu B; Xu C; Peng F; Yang B; Qiu Y; Sun Y; Wang S; Guo H
    Ann Pharmacother; 2017 Sep; 51(9):735-742. PubMed ID: 28573932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
    Lefebvre MC; St-Onge M; Glazer-Cavanagh M; Bell L; Kha Nguyen JN; Viet-Quoc Nguyen P; Tannenbaum C
    Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.